| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 14568740 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 247 journal articles in the PubMed database | Email to a friend | | |
| Sorensen PS, Ross C, Clemmesen KM, et al.
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Lancet 2003 Oct 11; 362(9391):1184-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sørensen S, Koch-Henriksen NJ, Pedersen CR, et al.
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis] [Journal Article]
Ugeskr Laeger 2004 Oct 4; 166(41):3606-9.
Full Citation | Find Related Articles | | Sorensen P, Koch-Henriksen N, Bendtzen K
Are ex vivo neutralising antibodies against IFN-{beta} always detrimental to therapeutic efficacy in multiple sclerosis? [Journal Article]
Mult Scler 2007 Jun; 13(5):616-21.
Abstract | Full Citation | Find Related Articles | | Durelli L, Barbero P, Bergui M, et al.
MRI activity and neutralizing antibody as predictors of response to IFN-{beta} treatment in MS. [JOURNAL ARTICLE]
J Neurol Neurosurg Psychiatry 2007 Nov 6.
Abstract | Full Citation | Find Related Articles | | McCormack PL, Scott LJ
Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis. [Journal Article, Review]
CNS Drugs 2004; 18(8):521-46.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Koch-Henriksen N, Sørensen PS
The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Mult Scler 2000 Jun; 6(3):172-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Petkau AJ, White RA, Ebers GC, et al.
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis. [Journal Article]
Mult Scler 2004 Apr; 10(2):126-38.
Abstract | Full Citation | Find Related Articles | | Malucchi S, Sala A, Gilli F, et al.
Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. [Journal Article]
Neurology 2004 Jun 8; 62(11):2031-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Río J, Nos C, Tintoré M, et al.
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials. [Clinical Trial, Journal Article]
Ann Neurol 2002 Oct; 52(4):400-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
